Merritt C Maduke's lab focuses on understanding chloride channels, particularly the CLC-Ka channel in the kidney, which plays a vital role in regulating water and solute balance in the body. They aim to develop specific inhibitors for this channel, which could lead to new treatments for conditions like hyponatremia that affect kidney function. By combining advanced structural biology techniques with medicinal chemistry, the lab seeks to create effective drugs that could improve patient outcomes in various kidney-related diseases.

The research lab led by Liang Feng at Stanford University focuses on understanding how mitochondrial membrane transport systems influence cellular energy production and signaling. By investigating the mechanisms of calcium transport and other critical processes within mitochondria, they aim to uncover how these systems contribute to normal physiology and diseases such as metabolic, cardiovascular, and neurodegenerative disorders. This work may also lead to new therapeutic strategies targeting these transport systems.

Dr. Brian Kobilka's lab at Stanford University focuses on understanding how G protein-coupled receptors (GPCRs) work. These receptors play a crucial role in receiving signals from neurotransmitters and hormones, which helps control various bodily functions. The lab's research aims to uncover the structural and dynamic properties of GPCRs, particularly in how they signal through different pathways, including those involved in pain relief and side effects from drugs like opioids. This knowledge can lead to the development of better and safer medications.

Dr. Lucy Erin O'Brien's lab at Stanford University focuses on how the intestinal epithelium repairs itself after injury using the Drosophila model. The team studies the balance between rapid cell differentiation and the potential long-term consequences on stem cell populations. By observing how the gut handles injury and recovery, they aim to find new strategies to promote intestinal healing and manage chronic intestinal diseases.

Dr. Huttenhain's lab studies the mu-opioid receptor (MOR), a key player in pain relief and addiction. By investigating how MOR interacts with different signaling pathways and its location within cells, they aim to discover safer pain management strategies with fewer side effects. Using advanced techniques such as proteomics and CRISPR, the lab seeks to identify new molecular targets that could lead to better treatments for pain and opioid addiction.